Not angry. I never heard of the company before and did a quick look and wasn't hard to see that they had plenty of problems. I think the Aspire deal was nothing more than some of them cashing in and getting out. The Aspire deal has been handle as a funding for trials with CTIX and the company has been very frugal with those funds, as can be seen if you go through all the finical reporting and compare them to the progress made in the trials for current drugs in the CTIX pipeline.

If I was angry I would have told you to take "something" put it "somewhere" and ride it over the other board with the other tools. I gave you the benefit of the doubt of maybe actually not doing any good DD(due diligence).

GLTM